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Efficient national surveillance for health-
care-associated infections
B. A. D. van Bunnik1*, M. Ciccolini2, C. L. Gibbons1, G. Edwards3, R. Fitzgerald4, P. R. McAdam4, M. J. Ward1,
I. F. Laurenson5 and M. E. J. Woolhouse1
Abstract
Background: Detecting novel healthcare-associated infections (HCAI) as early as possible is an important public health
priority. However, there is currently no evidence base to guide the design of efficient and reliable surveillance systems.
Here we address this issue in the context of a novel pathogen spreading primarily between hospitals through the
movement of patients.
Methods: Using a mathematical modelling approach we compare the current surveillance system for a HCAI that
spreads primarily between hospitals due to patient movements as it is implemented in Scotland with a gold standard to
determine if the current system is maximally efficient or whether it would be beneficial to alter the number and choice
of hospitals in which to concentrate surveillance effort.
Results: We validated our model by demonstrating that it accurately predicts the risk of meticillin-resistant Staphylococcus
aureus bacteraemia cases in Scotland.
Using the 29 (out of 182) sentinel hospitals that currently contribute most of the national surveillance effort results in
an average detection time of 117 days. A reduction in detection time to 87 days is possible by optimal selection of 29
hospitals. Alternatively, the same detection time (117 days) can be achieved using just 22 optimally selected hospitals.
Increasing the number of sentinel hospitals to 38 (teaching and general hospitals) reduces detection time by 43 days;
however decreasing the number to seven sentinel hospitals (teaching hospitals) increases detection time substantially
to 268 days.
Conclusions: Our results show that the current surveillance system as it is used in Scotland is not optimal in detecting
novel pathogens when compared to a gold standard. However, efficiency gains are possible by better choice of sentinel
hospitals, or by increasing the number of hospitals involved in surveillance. Similar studies could be used elsewhere
to inform the design and implementation of efficient national, hospital-based surveillance systems that achieve
rapid detection of novel HCAIs for minimal effort.
Background
Healthcare-associated infections (HCAI) are a major
concern for hospitals worldwide [1, 2]. HCAIs can
spread rapidly throughout a network of hospitals [3, 4].
Rapid intervention for such outbreaks is of major im-
portance, firstly to keep the number of infected patients
to a minimum and secondly because there are consider-
able costs associated with large disease outbreaks [5, 6].
Examples of HCAIs causing concern are those caused
by both meticillin-susceptible Staphylococcus aureus
(MSSA) and methicillin-resistant Staphylococcus aur-
eus (MRSA) as well as multi drug resistant gram nega-
tive bacteria, glycopeptide-resistant enterococcus and
Clostridium difficile.
The need for efficient and reliable surveillance for
HCAIs is recognised internationally [7, 8], but different
countries have adopted different approaches to the imple-
mentation of a surveillance system. For example, in
Scotland there is the Scottish Healthcare Associated Infec-
tion Programme supported by Health Protection Scotland
(HPS) and the Scottish MRSA Reference Laboratory [9]
which collectively gather data and monitor trends in the
number of MRSA bacteraemias as well as antimicrobial
resistance and virulence profiles. Elsewhere in the UK,
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amongst other systems, there are the voluntary reporting
of all bacteraemias, the mandatory MRSA bacteraemia
surveillance and the British Society for Antimicrobial
Chemotherapy Resistance Surveillance Project [10].
Further examples are the European Antimicrobial Re-
sistance Surveillance Network (EARS-Net) in Europe
[11], the National Healthcare Safety Network (NHSN)
in the United States of America [12] and the National
Surveillance Initiative in Australia [13]. Unfortunately,
there is not a good evidence base to guide the design of
national surveillance programmes.
In this study, we assess the current laboratory based
surveillance system for hospitals in Scotland in terms of
efficiency in detecting a novel outbreak of an HCAI
spread predominantly by direct patient contact and
movement of patients between health care facilities,
measured as the time to first detection and as the num-
ber of hospitals affected before detection. Efficiency is
important because a more efficient surveillance system
would detect outbreaks at an earlier stage when fewer
hospitals and fewer patients are affected by an HCAI
and decrease expenditure because fewer patients have to
be treated.
Previous studies show that movement of patients is
likely to play an important role in the spread of HCAIs
as the patients act as vectors carrying pathogens from
one hospital to the next [14–21].
Therefore, we use a recently developed mathematical
model [22] to simulate the spread of a novel HCAI
spread predominantly by direct patient movement be-
tween Scottish hospitals as a result of patient move-
ments, i.e. with little or no spread in the community,
and extend it by comparing existing surveillance pro-
grams with a (putative) optimal program to see if, with
easily acquired information on the network of patient
transfers, existing national surveillance schemes can be
made more efficient. The model enables us to prioritise
hospitals for inclusion in a laboratory surveillance system
and thereby to address two key questions: 1) What is the
optimal distribution of surveillance effort across hospitals
and is the current system maximally efficient; and 2)
Would there be benefits from increasing or decreasing the
number of hospitals engaged in surveillance?
Methods
Patient movement data and the hospital network
For the purposes of this study, a “hospital” was defined
as: a secondary healthcare facility with at least one in-
patient per year and with at least one hospital specialty
or department. Scottish hospitals were identified from
those listed in Information Services Division (ISD) cost
book reports for the financial year 2007-08 (R020 and
R020LS, http://www.isdscotlandarchive.scot.nhs.uk/isd/
6058.html) and were classified according to the termin-
ology used by the ISD.
To quantify movements of patients between these hos-
pitals we used patient admission data obtained on request
from the ISD (http://www.isdscotland.org/). The patient
admission data covered all admissions to healthcare facil-
ities in Scotland between 01-01-2007 and 31-12-2007.
From this dataset we extracted movements of patients be-
tween hospitals as either direct transfers, i.e. from one
hospital directly to another hospital, or indirect transfers,
i.e. when a patient is discharged from one hospital into
the community and later (within the period covered by
the data) admitted to another hospital.
We derived a movement matrix for all connected hos-
pitals in Scotland by calculating for every hospital pair
(i,j), the number of patients being moved from hospital j
to hospital i, here denoted as wi,j, resulting in a N×N
matrix of movements between hospitals, with N being
the total number of hospitals that have connections with
other hospitals.
From the patient admission dataset, movements be-
tween pairs of hospitals were identified for 182 unique
hospitals (as defined above). Table 1 shows the types, as
defined in the ISD costs book, and numbers of hospitals
that were included in the analysis.
Bacteraemia case data
Staphylococcus aureus bacteraemia case data (number of
MRSA and MSSA bacteraemia cases) for the year 2007
and stratified by hospital, were provided by Health Pro-
tection Scotland (HPS), NHS National Services Scotland,
Glasgow, Scotland, UK. PAC 54/11. Caldicott approval
Table 1 Hospital types and number of occurrences of a
particular type
Hospital Type Count
Community hospitals 57
Large general hospitals 18
Long stay/psychiatric hospitals 16
Mental illness hospitals 14
Small long stay hospitals 14
General hospitals 13
Teaching hospitals 7
Long stay hospitals 6
Long stay/acute hospitals 6
Teaching mental illness hospitals 5
Learning disabilities hospitals 3
Sick children’s hospitals 3
Dental hospitals 2
Maternity hospitals 1
Other 17
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was gained for this project and for the release of these
data through HPS. From this dataset, the bacteraemia
case data for the 182 hospitals that were included in the
movement matrix were extracted and used in subse-
quent analysis.
Current surveillance system in Scotland
The current surveillance system in Scotland consists of
National Health Service (NHS) laboratories that receive
specimens from the hospital or hospitals that they are
associated with, mostly larger hospitals but some also
cover up to five smaller, local hospitals. All laboratories
report notifiable and other specified alert organisms to
HPS. Those hospitals that do not have a laboratory
send their specimens to another nearby hospital. Of the
182 hospitals in our study, 29 were associated with an
NHS laboratory.
Prioritising schemes
Three different prioritising schemes were used to assess
both the current surveillance system in Scotland and two
potentially better performing schemes. For the current
surveillance system in Scotland we used the 29 hospitals
with NHS laboratories according to their surveillance ac-
tivity, i.e. hospitals that sent samples in 2007, we call this
scheme “currently surveillance active”. Furthermore, we
used a prioritising scheme based on the hospital category
a hospital belonged to. Therefore we used either only
teaching hospitals (seven in total in our network) or a
combination of teaching hospital, large general hospitals
and general hospitals (denoted as T + LG+G in figures
and tables). Lastly, as a gold standard, we used a so-called
greedy algorithm. Table 2 shows the median hospital size
and the median number of patients received for the hospi-
tals in the different prioritising schemes. Full details of
how this greedy algorithm works can be found in [22] but,
briefly, a greedy algorithm selects the first hospital to in-
clude as a sentinel hospital for surveillance based on the
lowest average time to first infection (detection time) over
all simulations. The next hospital is chosen in such a way
that it minimises the average detection time when this
hospital is added to the already existing list of sentinel
hospitals. The greedy algorithm thus generates a putative
optimal ordering of hospitals to be included in a national
surveillance system.
Mathematical model
Our modelling approach followed Ciccolini et al.
[22] Briefly, we formulated a stochastic, discrete-
time, Susceptible-Infectious model to simulate the
spread of the pathogen between hospitals in the net-
work. Three relevant assumptions of the model are
that the pathogen spreads between hospitals predom-
inately as a result of patient movements (as defined
above), that it spreads much faster within a hospital
than between hospitals, and that once infection is
present in a hospital it remains there throughout the
period of interest. A full discussion of these and
other model assumptions is provided in the original
publication [22].
To transmit the pathogen from one hospital to the
next, a patient has to be a carrier of the pathogen when
discharged, remain colonised or infected with the patho-
gen until being admitted to the next hospital, and then
transfer the pathogen to another patient within this
(subsequent) hospital. We combined the individual
probabilities of these events into a single value, β, the
probability of transmission per patient movement.
Combining the per patient probability of transmission
and the number of referrals to a hospital, the probability
of a hospital becoming infected and infectious can be
written as:
PS→Ii tð Þ ¼ 1−
Y
j:Hj∈I
1−βð Þwi;jΔt
Here PS→ I(t) is the probability of a susceptible hos-
pital becoming infected by an infectious hospital at time
t, during one time-step Δt (Δt = 1 day was used through-
out this paper), I is the set of all hospitals that are cur-
rently infectious, β is the per patient probability of
transmission and wi,j is the rate at which patient move
from hospital j to hospital i. Thus, we calculate the con-
tribution to the probability of infection of all currently
(i.e. at time point t) infectious hospitals that transfer pa-
tients to hospital i. One of the assumptions of this model
is that the parameters do not change over time or vary
with hospital characteristics, such as hospital size. Other
studies have shown that MRSA prevalence might be
higher in larger hospitals [23, 24]. However we did not
take this into account in our analyses.
Table 2 Median hospital size and number of patients received for the different priority lists. For hospital size the number of occupied bed
days in the year 2007 was used as a proxy
Priority list Hospitals included Hospital size median (90 % range) Patients received median (90 % range)
Surveillance active 29 124,824 (17,776 – 282,595) 2925 (389 – 7746)
Teaching hospitals 7 261,207 (188,894 – 322,494) 6759 (3806 – 9517)
T + LG + G 38 109,819 (9649 – 263,346) 2820 (294 – 6858)
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Simulations
To assess the performance of the different prioritisation
schemes for surveillance the model was used to simulate
the spread of a pathogen in a network of hospitals. A
simulation time of 10 years was used throughout. The
index hospital was uniform randomly picked from the
list of available hospitals (see Additional file 1 for alter-
native choices of index hospital). Data on the status of
each hospital on each day of the simulation and the time
to first infection obtained for each hospital were re-
corded. All simulations for the comparison of the differ-
ent surveillance strategies were performed using baseline
values β = 0.001. This value was used by Ciccolini et al.
[22] and reproduces the observed increase in hospital-
level prevalence of EMRSA-15 and EMRSA-16 in
England and Wales between 1992 and 1997 [25]. For
surveillance purposes we assume that an (bloodstream)
infection is identified immediately and that there is no
difference between hospitals in times from infection to
detection. Response to infection is not explicitly in-
cluded in the model although control measures applied
across all infected hospitals and prevention measures ap-
plied across all uninfected hospitals are implicit in the
value of the parameter β.
Model fit
As a model-predicted risk estimate we used the reciprocal
of the average time to first infection tinf
  averaged over
the 20,000 simulations. To test how well HCAI risk, as pre-
dicted by the model, agreed with empirical data on MRSA
bacteraemia a Receiver Operating Characteristic (ROC)
analysis (see Additional file 1 for details on the analysis)
was employed. We calculated the area under the ROC
curve (AUC), which provides a measure of a model’s ability
to discriminate between hospitals that had MRSA bacter-
aemia cases, and those that did not [26]. We note that bac-
teraemia data do not capture asymptomatic carriage, but
we assume that these are correlated.
Impact of non-participating hospitals
In order to test the importance of full participation of
priority hospitals we studied the impact of removing
hospitals from the surveillance program. We systematic-
ally removed from one up to six hospitals and deter-
mined the effects on the average time until first
detection. We then took the worst case scenario, i.e. that
subset of remaining hospitals that showed the maximum
time until first detection.
Costs estimation
For a comparison of the costs involved with disease sur-
veillance we explored two options to estimate direct
costs associated with the different sentinel surveillance
schemes. For the first option it was assumed that there
is a fixed cost per hospital for surveillance. The second
option assumes that the costs are dependent on the num-
ber of patients a hospital receives from other hospitals in
the network, either via direct transfers or via indirect
transfers. It is assumed that all (or a set fraction of) incom-
ing patients are screened and that the expense per patient
is the same for all hospitals and all patients. The fixed and
variable approaches were calibrated to give the same total
cost when all hospitals were included.
Results
Patient movement data
From the patient admissions data for 2007, 182 hospitals
admitted patients who had previously been discharged
from a Scottish hospital within that year or discharged
patients who were subsequently admitted to another
hospital within Scotland in that year. Theoretically, this
could have led to 32,942 connections if all hospitals were
connected to all other hospitals. However, we identified
just 2360 connections (7.1 % of those possible). Figure 1
shows a map of the hospitals included and the connec-
tions between them (a line between two hospitals repre-
sents movement between the two connected hospitals,
in either direction). Furthermore we found that patients
who had spent time in the community between stays at
two different hospitals did so on average for a median
19 days; Additional file 1: Figure S1 shows the distribu-
tion of time spent in the community between subse-
quent admissions.
Simulation results
There was considerable variation (over the 20,000 simu-
lations) in the average time to infection for individual
hospitals predicted by the model, with modal times ran-
ging from 40 days to 3520 (Additional file 1: Figure S2).
The results of the ROC analyses are shown in Fig. 2. The
AUC is 0.97, indicating a very good fit of the model predic-
tion to data on MRSA bacteraemia cases in Scotland. If we
compare this to another measure as a predictor for MRSA
bacteraemia cases, hospital size (measured as the number
of staffed beds in a hospital), it is clear that our model fits
the bacteraemia case data better than hospital size, which
has an AUC of 0.88 (Additional file 1: Figure S3).
We compared the performance of the different
methods to create the priority list for a sentinel surveil-
lance system by two different measures: the detection
time and the number of hospitals affected before detec-
tion. Figure 3a shows the average detection time for the
different prioritisation methods against the fraction of
hospitals included in the surveillance system. Similarly,
Fig. 3b shows the average number of affected hospitals
before detection in the fraction of sentinel hospitals. The
results for the gold standard and the three other options
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(currently surveillance active, teaching hospitals only or
teaching hospitals + large general hospitals + general hos-
pitals) are also indicated in Fig. 3b. Detection times and
number of affected hospitals at detection was calculated,
for the above three options, by employing all the hospi-
tals participating in the surveillance programme. Table 3
shows the results in terms of number of hospitals in-
cluded and detection times of each method compared to
the gold standard.
This shows that if we include the currently surveil-
lance active hospitals (N = 29) this results in an average
detection time of 117 days (90th percentile: 308 days),
whilst optimal selection of 29 hospitals (i.e. from the
gold standard) would result in detecting the outbreak
30 days earlier (87 days, 90th percentile: 260 days) (see
also Fig. 3a). Alternatively, optimal selection to detect
the outbreak within 117 days would only need 22 hospi-
tals. If we include only the seven teaching hospitals as
Fig. 1 Hospitals included and their connections. Red open circles indicate a hospital and blue arrows indicate a connection (at least one patient
transferred) between the two hospitals
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sentinel hospitals in a surveillance scheme average de-
tection time would be 268 days (90th percentile:
595 days), an increase of 151 days.
The average number of hospitals affected before detec-
tion is 2.1 (90th percentile: 3 hospitals) for the currently
surveillance active hospitals, compared to 3.4 (90th per-
centile: 5 hospitals) if only teaching hospitals are in-
cluded. If the number of hospitals to include as sentinels
for surveillance is extended to all 38 teaching, large gen-
eral and general hospitals then the average detection
time is 74 days (90th percentile: 280 days), a decrease of
43 days compared to the currently surveillance active hos-
pitals. Similarly, the average number of hospitals affected
decreased by 0.4 hospital to 1.7 (90th percentile: 2) affected
hospitals.
The relative costs associated with different surveillance
schemes are depicted in Fig. 4. Two limiting cases are il-
lustrated: i) there is a fixed cost per hospital, so total
cost is proportional to the number of hospitals included;
and ii) costs are proportional to the number of patient
in-movements (from other hospitals, directly or indir-
ectly) per hospital. The actual costs will be a combin-
ation of fixed and pro rata costs and so are likely to fall
between these two extremes. Fixed costs, by definition,
rise linearly with the number of hospitals participating,
but are independent of the choice of hospitals. Variable
costs, however, tend to rise faster initially because larger
hospitals with more in-movements have higher priority,
and are dependent on the exact choice of hospitals. For
variable costs, the currently surveillance active hospitals
(green symbols in Fig. 4) not only have greater than
optimal detection time (Fig. 3a) but are also more costly.
Optimal selection of hospitals would therefore both im-
prove the performance of the surveillance system and re-
duce costs.
Discussion
In this study, we have constructed a network of all hospi-
tals in Scotland that are connected through the move-
ments of patients. Outbreaks of an HCAI were simulated
over this network in order to identify those hospitals that
are most prone to being infected with an emerging patho-
gen spread by patient movements and to assess different
prioritisations of hospitals for inclusion in surveillance sys-
tems for early detection of a novel pathogen spreading be-
tween hospitals. In Scotland, the vast majority of MRSA
bacteraemia cases are caused by the strains EMRSA-15
and EMRSA-16, both of which are strongly associated with
hospitals [27]. Therefore we tested how well the risk, as
predicted by the model, fitted with bacteraemia case-data
using an ROC analysis which shows that the model accur-
ately predicts the risk of a hospital being affected (Fig. 2).
We assessed the performance of the current laboratory
based surveillance system as it is implemented in Scotland
as well as two other possible surveillance schemes and a
putative optimal surveillance scheme. Our results show
that if hospitals are prioritised on their surveillance activ-
ity, as indicated by whether they submitted samples to the
SMRSARL in 2007 (N = 29), the average detection time
before detection is significantly above the optimum, al-
though the expected number of hospitals affected is near
the optimum. However, if fewer hospitals were included in
a surveillance scheme, i.e. only teaching hospitals (N = 7),
this would increase the average time to first detection by
about 150 days (Fig. 3a and Table 3). If, on the other hand,
more hospitals were included, i.e. all teaching, large gen-
eral and general hospitals (N = 38), this would decrease
the average detection time by 43 days. However, our re-
sults do reveal diminishing returns: as more hospitals are
included, less is gained in terms of detection time or num-
ber of affected hospitals (Fig. 3a and b). The number of
hospitals to be included will ultimately be dictated by what
is judged an ‘acceptable’ time before detection, although
that number is minimised by using the methodology de-
scribed here. That decision will depend on a number of
factors, such as the cost of treating an infection, the risk
of onward spread and the need for hospital-wide prevent-
ive measures.
Furthermore, Fig. 4 shows that optimal selection of
hospitals to be included in a sentinel surveillance system
can also reduce direct cost of surveillance. Here we have
used a very simple estimate of the costs associated with
surveillance; we assume that all or a fixed proportion of
patients who have been at another hospital within the
past 12 months are screened clinically and, if indicated,
Fig. 2 The ROC curve for the comparison between bacteraemia
cases in Scotland and predictions of the stochastic network model.
The x-axis shows the false positive rate and the y-axis shows the true
positive rate. The AUC = 0·97
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by culture upon arrival and that these costs linearly in-
crease with each patient. In practice, hospitals in
Scotland currently use “clinical risk assessment” (CRA)
to assess patients that enter the hospital. Asymptomatic
patients are not screened automatically for bacteraemia
by taking blood cultures, but surveillance swabs for the
detection of MRSA carriage may be taken depending on
the CRA assessment outcome [9].
This study has some limitations that should be consid-
ered. We assumed that all affected hospitals have detect-
able infections (using MRSA bacteraemia as an exemplar).
Affected hospitals with only asymptomatically colonized
Fig. 3 a. Sentinel surveillance system performance. Average detection time of a novel HCAI, following emergence in a single randomly selected
hospital versus number of hospitals participating in surveillance. The solid black line corresponds to the gold standard ‘greedy’ algorithm; the
coloured points indicate the average detection time after including all hospitals in that particular list. Dashed coloured lines are plotted as
reference lines. b. As 3a but showing the average number of affected hospitals
Table 3 Detection for the different priority lists when all hospitals of that particular list are included as sentinel hospitals. Gold standard
hospitals needed indicates the number of hospitals that would be needed using the gold standard algorithm to detect an outbreak in
the same time as using the priority list. Gold standard detection time indicates the detection time needed with the greedy algorithm if
the same number of hospitals would be included from the priority list based on the Gold standard algorithm
Priority list Hospitals included Detection time (days) Gold standard hospitals needed Gold standard detection time (days)
Surveillance active 29 117 22 87
Teaching hospitals 7 268 6 241
T + LG + G 38 74 34 64
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patients would either be missed or detection delayed until
bacteraemia cases appear. However, the original model
[22] was calibrated using case data for bloodstream MRSA
infections and not on colonisation case data, so this is
already taken into account. Furthermore we chose a spe-
cific value for β consistent with the observed rate of
spread of MRSA in England [22]. A sensitivity analysis
shows that our results and conclusions are robust to
changes in the value for β. Although the speed with which
the disease spreads over the network is influenced by β,
the results (in terms of efficiency of existing surveillance
schemes compared to a gold standard) do not change sig-
nificantly (see Additional file 1: Figure S6 for sensitivity
analysis results). Moreover these simulations show that
for higher values of β the need for an efficient surveillance
system is even more important as there is less time to de-
tect an (emerging) infection.
Lastly, the results found in this study depend on the
correctness of the model and all implicit and explicit as-
sumptions that were made. We showed that the risk as
predicted by the model is fitting well to empirical data,
which strengthens confidence in the model and its
assumptions.
As mentioned before, hospitals that do not have a
microbiology laboratory may send their samples to a
nearby (large) hospital, and this makes those larger hospi-
tals even more important for surveillance purposes (and
also making the current system more robust). If only a
few large hospitals are included in the sentinel surveillance
scheme (i.e. teaching hospitals only) then not only do de-
tection times increase but the non-participation of just
one of the hospitals could have a significant impact on the
time to first detection (Additional file 1: Figure S4). Sur-
veillance systems that include more hospitals tend to be
more robust to non-participation.
Conclusion
To conclude, in this paper we have demonstrated that
the current laboratory based surveillance system as it is
used in Scotland to detect novel pathogens spreading by
means of patient movements is less efficient than a puta-
tive optimal surveillance system in time to first detection
of a HCAI. We have shown that this time until first de-
tection can be reduced either by increasing the number
of hospitals participating in surveillance or by optimally
selecting which hospitals to include in a surveillance sys-
tem. Similar studies elsewhere could be used to inform
national health care services on the design and imple-
mentation of efficient surveillance systems that achieve
rapid detection of novel HCAIs for minimal effort.
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